Henry Schein Stock Forecast, Price & News

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HSIC stock has increased by 9.0% and is now trading at $62.85.
View which stocks have been most impacted by COVID-19.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Henry Schein.

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Henry Schein.

Henry Schein, Inc. (NASDAQ:HSIC) issued its quarterly earnings results on Tuesday, May, 5th. The company reported $0.94 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.74 by $0.20. The firm had revenue of $2.43 billion for the quarter, compared to analysts' expectations of $2.32 billion. Henry Schein had a net margin of 6.35% and a return on equity of 11.51%. The firm's revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.80 EPS.
View Henry Schein's earnings history.

Shares of Henry Schein split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

Henry Schein declared that its Board of Directors has authorized a share buyback plan on Thursday, October 31st 2019, which permits the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 4.3% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board of directors believes its shares are undervalued.

13 equities research analysts have issued 12-month target prices for Henry Schein's stock. Their forecasts range from $50.00 to $80.00. On average, they expect Henry Schein's stock price to reach $63.73 in the next twelve months. This suggests a possible upside of 1.4% from the stock's current price.
View analysts' price targets for Henry Schein.

Henry Schein saw a decline in short interest in August. As of August 31st, there was short interest totaling 9,610,000 shares, a decline of 12.1% from the August 15th total of 10,930,000 shares. Based on an average daily trading volume, of 1,410,000 shares, the short-interest ratio is presently 6.8 days. Approximately 6.8% of the company's stock are short sold.
View Henry Schein's Short Interest.

Some companies that are related to Henry Schein include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), NVIDIA (NVDA), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Micron Technology (MU), CVS Health (CVS), Intel (INTC) and AT&T (T).

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Henry Schein's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.01%), Alecta Pensionsforsakring Omsesidigt (2.56%), Bank of New York Mellon Corp (1.72%), State of Wisconsin Investment Board (1.30%), AQR Capital Management LLC (1.07%) and Sound Shore Management Inc CT (1.01%). Company insiders that own Henry Schein stock include David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends for Henry Schein.

HSIC stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Alecta Pensionsforsakring Omsesidigt, Bank of Montreal Can, Glenmede Trust Co. NA, Prudential PLC, APG Asset Management N.V., State of Tennessee Treasury Department, and UBS Group AG. Company insiders that have sold Henry Schein company stock in the last year include Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Stanley M Bergman, Steven Paladino, and Walter Siegel.
View insider buying and selling activity for Henry Schein.

HSIC stock was bought by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Nordea Investment Management AB, Sound Shore Management Inc CT, FMR LLC, Russell Investments Group Ltd., Strs Ohio, DNB Asset Management AS, and Bank of America Corp DE.
View insider buying and selling activity for Henry Schein.

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HSIC stock can currently be purchased for approximately $62.85.

Henry Schein has a market capitalization of $8.97 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe.

The official website for Henry Schein is www.henryschein.com.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]